JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krayer, O.
Right arrow Articles by George, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krayer, O.
Right arrow Articles by George, H. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 103, Issue 3, 249-258, 1951
Copyright © 1951 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON VERATRUM ALKALOIDS. XV. THE QUININE-LIKE EFFECT OF VERATRAMINE UPON THE SINGLE TWITCH AND UPON THE "VERATRINE RESPONSE" OF THE SARTORIUS MUSCLE OF THE FROG

Otto Krayer 1 and H. W. George 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts

The secondary veratrum alkamine, veratramine, has an action upon the response of the isolated sartorius muscle of the frog to electrical stimulation, which is qualitatively and quantitatively very similar to the well known action of quinine. Veratramine increases the height of the single twitch in concentrations (w/v) of 1:300,000 to 1:100,000. In concentrations of 1:30,000 and 1:10,000, the increase in twitch height is transient; the twitch diecreases progressively and eventually the muscle no longer responds to the electrical stimulus. The "veratrine response", caused by veratridine 1:10 million or 1:5 million, is antagonized by veratramine 1:100,000, and the normal twitch is restored in a large percentage of the experiments.

Attention is drawn to other substances which—like quinine, quinidine and veratramine—are capable of antagonizing the "veratrine response", for example, the cardiac glycosides, ouabain and! digoxin, and the ergot alkaloid, dihydroergotamine.

Submitted on July 16, 1951







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1951 by the American Society for Pharmacology and Experimental Therapeutics.